Latest Capital Raises News

FireFly Metals has agreed to sell its Ontario gold assets, including a 70% stake in the Pickle Crow Project, to Bellavista Resources for up to A$86.1 million in scrip. FireFly shareholders will receive Bellavista shares, maintaining exposure to the assets while FireFly focuses on its copper-gold ambitions.

FireFly Metals has agreed to sell its Ontario gold assets to Bellavista Resources for up to A$86.1 million in shares and performance rights, unlocking value for shareholders while focusing on its copper-gold growth strategy.

Cyprium Metals has completed the first tranche of a A$36 million placement, positioning itself to fast-track exploration and production growth at its Nifty Copper Complex in Western Australia.

PYC Therapeutics has launched a A$653 million capital raising to fund the clinical advancement of four RNA-based drug candidates targeting genetic diseases with significant unmet needs. The raise extends the company’s cash runway to 2030, supporting key clinical milestones and a transition to commercialisation.

PYC Therapeutics has launched a substantial $653 million equity raise to fund clinical trials for four promising drug candidates targeting genetic diseases. This capital injection aims to advance the company’s pipeline through critical human efficacy milestones.

Adavale Resources has raised $5.15 million in a strongly supported placement to fund an expanded drilling program at its London Victoria Gold Mine and advance regional exploration efforts.

West Wits Mining has announced a substantial 44% increase in its gold resource at the Witwatersrand Basin Project, boosting the total to 7.24 million ounces and setting the stage for imminent production at Qala Shallows.

Genetic Signatures has appointed Maria Halasz as its new CEO, bringing over two decades of leadership in life sciences and capital markets to steer the company’s global expansion.

Cluey Ltd has terminated its planned acquisition of Education Futures Group, the parent of Art of Smart, citing unmet conditions. The company remains focused on expanding its blended learning offerings and exploring new acquisition opportunities.

Brightstar Resources has successfully raised $180 million through a $175 million institutional placement and a $5 million share purchase plan, fully funding its Goldfields development and advancing the Sandstone project towards a final investment decision.

Orthocell Ltd reports steady progress in commercialising its nerve repair product Remplir in the US, with sales growth, expanded distributor networks, and manufacturing upgrades underpinning its path to profitability.

Taiton Resources has completed a significant placement of nearly 12 million shares to Singapore’s GEMS Strategic Resource Fund, bolstering its capital position and signalling confidence from a reputable international investor.